Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immatics
Biotech
With $1.7B Immatics deal, Moderna bets again on cancer vaccines
Moderna is doubling down in cancer vaccines and cell therapies with a new Immatics research partnership that could top $1.7 billion in milestones.
Annalee Armstrong
Sep 11, 2023 8:12am
Immatics' stock soars on PRAME prospect's solid tumor data
May 3, 2023 9:35am
GSK severs Immatics partnership in further T-cell retreat
Nov 17, 2022 11:00am
BMS-backed Immatics touts early data, prompting $110M offering
Oct 10, 2022 1:23pm
Immatics finds a pan-cancer target for T-cell therapies
Aug 31, 2022 4:20pm
Bristol Myers triples-down on Immatics, bringing deal to $4.2B
Jun 2, 2022 11:48am